bioAffinity Technologies, Inc. (BIAF)
NASDAQ: BIAF · Real-Time Price · USD
1.730
-0.150 (-7.98%)
At close: Jun 5, 2026, 4:00 PM EDT
1.770
+0.040 (2.31%)
After-hours: Jun 5, 2026, 7:56 PM EDT

bioAffinity Technologies Revenue

bioAffinity Technologies had revenue of $1.35M in the quarter ending March 31, 2026, a decrease of -27.09%. This brings the company's revenue in the last twelve months to $5.66M, down -35.75% year-over-year. In the year 2025, bioAffinity Technologies had annual revenue of $6.16M, down -34.18%.

Revenue (ttm)
$5.66M
Revenue Growth
-35.75%
P/S Ratio
1.39
Revenue / Employee
$99,296
Employees
57
Market Cap
7.84M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20256.16M-3.20M-34.18%
Dec 31, 20249.36M6.83M269.68%
Dec 31, 20232.53M2.53M52,627.44%
Dec 31, 20224.80K--
Dec 31, 2021---
Dec 31, 2020 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Inotiv507.36M
MDxHealth110.97M
Burning Rock Biotech77.14M
Exagen68.38M
XWELL28.83M
Precipio25.83M
iSpecimen1.03M
Quantum Cyber537.08K
Revenue Rankings